World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   3759 records for 1063 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
AuthorisedEUCTR2014-000358-13-LV
A clinical trial to assess a novel medicine in the treatment of patients with moderately to severely active rheumatoid arthritis
11/09/2014
Not recruitingNCT02226120
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
25/08/2014
Not RecruitingCTRI/2014/08/004922
A clinical trial to study the effects of two drugs, Folfox and CT-011 in patients with cancer of large intestine.
25-08-2014
Not recruitingNCT02226627
Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrición y Salud
22/08/2014
Not RecruitingCTRI/2014/08/004868
A clinical trial intended to compare safety and efficacy of two formulations in patients with metastatic Colorectal Cancer (mCRC).
12-08-2014
AuthorisedEUCTR2011-005019-96-CZ
Efficacy and Safety Study of Romiplostim in Paediatrics with Immune Thrombocytopenia
Recruitment statusMain IDPublic titleDate of registration
Not AvailableEUCTR2011-005019-96-Outside-EU/EEAEfficacy and Safety Study of Romiplostim in Paediatrics with Immune Thrombocytopenia24/09/2014
11/08/2014
AuthorisedEUCTR2014-002009-40-BE
MK-3475 vs. paclitaxel, Docetaxel or vinflunine in metastatic urothelial cancer 07/08/2014
AuthorisedEUCTR2014-001473-14-LT
OS Study of pembrolizumab (MK-3475) vs. SOC in Treatment Naïve Subjects with PD-L1 Positive Advanced or Metastatic NSCLC (Keynote 042) 06/08/2014
AuthorisedEUCTR2012-004303-12-RO
A study to evaluate the safety and efficacy of the addition of a new drug (MK-3102) in patients with Type 2 Diabetes between the age of 18 and 44 years old, who are not taking any medications
05/08/2014
AuthorisedEUCTR2013-004867-29-AT
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab
31/07/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history